Major Deal in the Pharmaceutical Sector in the USA

Published:

Major Deal in the Pharmaceutical Sector in the USA
Photo: Richard Drew/AP/TT

The American pharmaceutical and medical technology giant Johnson & Johnson has made an agreement to buy the biomedicine company Intra-Cellular Therapies.

Johnson & Johnson's bid is 132 dollars per share, which means a valuation of Intra-Cellular of around 14.6 billion dollars (approximately 165 billion kronor).

Intra-Cellular specializes in developing treatments for patients with disorders in the central nervous system.

Loading related articles...

Tags

Author

TTT
By TTEnglish edition by Sweden Herald, adapted for our readers

More news

Loading related posts...